Cibc World Markets Corp Takes $45,000 Position in Arbutus Biopharma Co. (NASDAQ:ABUS)
Cibc World Markets Corp bought a new position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,672 shares of the biopharmaceutical company’s stock, valued at approximately $45,000. Other institutional investors and hedge funds […]
Cibc World Markets Corp bought a new position in shares of Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 13,672 shares of the biopharmaceutical company’s stock, valued at approximately $45,000. Other institutional investors and hedge funds […]
